Why Immunotherapy Works for Some, But Not All, Mesothelioma Patients
May 05, 2026
May 05, 2026
MIAMI, Florida, May 5 -- The University of Miami Miller School of Medicine posted the following news:
* * *
Why Immunotherapy Works for Some, But Not All, Mesothelioma Patients
*
New research points to DNA methylation as a key factor in predicting who may respond to treatment and a potential new way to target resistant tumors.
Immunotherapy has transformed cancer treatment, but not all patients respond. In pleural mesothelioma, a . . .
* * *
Why Immunotherapy Works for Some, But Not All, Mesothelioma Patients
*
New research points to DNA methylation as a key factor in predicting who may respond to treatment and a potential new way to target resistant tumors.
Immunotherapy has transformed cancer treatment, but not all patients respond. In pleural mesothelioma, a . . .
